Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Nagoya
Clinical trial register · Japan

Clinical Trials in Nagoya, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2493 matching records held by the registry are in this view. Synced 22 Oct 2026, 03:19 UTC
2493
Studies in scope
all four open statuses
1263
Recruiting now
open to new participants
349
Lead sponsors
across recruiting studies
Top sites
Nagoya 31 Yokohama 27 Kashiwa 20 Sapporo 20 Sendai 18
Narrow the registerReset
Recruitment status
Phase
Site location
Nagoya31 Yokohama27 Kashiwa20 Sapporo20 Sendai18
All 142 locations
Target enrolment
to

Trials with a site in Nagoya

31 of 2493 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Recruiting
Pfizer
Phase 3
1,375
Nagoya, Kagoshima, Yokohama, Sakai, Saitama, Chuo-ku, Tachikawa, Toshima-ku
2026-08-24
Recruiting
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
NCT07476287Small Cell Lung Cancer, Small Cell Lung Cancer ( SCLC ), Transformed Small Cell Lung Cancer, Lung Neoplasms
Pfizer
Phase 2
40
Nagoya, Kita, Hirakata, Chūō, Kotoku, Osaka
2026-07-02
Recruiting
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
NCT07392892Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma, Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, Esophageal Adenocarcinoma
Pfizer
Phase 2/3
840
Nagoya
2026-05-14
Recruiting
Pfizer
Phase 2/3
1,156
Nagoya, Fukuoka, Iizuka-shi, Kure, Ginowan, Sakai, Fujieda, Hachiōji
2026-02-11
Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT07222566Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
Pfizer
Phase 3
1,410
Nagoya, Chiba, Matsuyama, Kurume, Otashi, Asahikawa, Sapporo, Kobe
2026-01-06
Recruiting
Pfizer
Phase 3
800
Nagoya, Chiba, Kashiwa, Yokohama, Hidaka, Kitaadachi-gun, Nagaizumi-cho, Koto-ku
2025-12-11
Recruiting
Pfizer
Phase 3
32,500
Nagoya, Iizuka-shi, Itoshima, Kitakyushu-shi, Onga-gun, Koga, Kumamoto, Ōmura
2025-12-10
Recruiting
Pfizer
Phase 1/2
138
Nagoya, Kashiwa, Sakai, Chuo-ku, Fukuoka
2025-12-01
Recruiting
Pfizer
Phase 2/3
982
Nagoya, Chiba, Kashiwa, Kita-gun, Kawasaki, Yokohama, Suita, Nagaizumi-cho
2025-10-03
Active, closed
Pfizer
Phase 1/2
74
Nagoya, Yokohama, Suita, Chuo-ku, Koto
2025-06-30
Active, closed
Pfizer
Phase 3
1,035
Nagoya, Otashi, Sapporo, Yokohama, Sakyo-ku, Sendai, Suita, Bunkyo-ku
2025-01-06
Active, closed
Pfizer
Phase 3
394
Nagoya, Sendai, Sakai, Bunkyo-ku, Shinjuku-ku, Kofu
2024-01-19
Active, closed
Pfizer
Phase 3
1,571
Nagoya, Sakura, Urayasu, Takarazuka, Inashiki-gun, Ikoma, Habikino, Hamamatsu
2023-11-08
Active, closed
Pfizer
Phase 3
59
Nagoya, Kashiwa, Chuo-ku
2023-08-09
Active, closed
Pfizer
Phase 3
624
Nagoya, Chiba, Kashiwa, Sapporo, Yokohama, Suita, Ina-machi, Bunkyo-ku
2023-03-03
Recruiting
Pfizer
Phase 3
173
Nagoya, Sapporo, Iruma-gun
2022-12-28
Active, closed
Pfizer
Phase 1
6
Nagoya, Kashiwa, Chuo-ku
2022-08-16
Active, closed
Pfizer
Phase 3
854
Nagoya, Maebashi, Kobe, Yahaba-cho, Kyoto, Sendai, Hamamatsu, Sunto-gun
2022-03-25
Active, closed
Lorlatinib Continuation Study
NCT05144997Non-Small-Cell Lung Cancer, NSCLC
Pfizer
Phase 4
76
Nagoya
2021-12-28
Active, closed
Crizotinib Continuation Clinical Study
NCT05160922NSCLC, ALCL, IMT
Pfizer
Phase 4
27
Nagoya
2021-12-27
Recruiting
Pfizer
Phase 3
245
Nagoya, Azumino, Kashihara, Lruma-gun, Saitama-shi, Hiroshima, Saga
2021-11-17
Recruiting
Pfizer
Phase 3
893
Nagoya, Yoshida-gun, Shibukawa, Yahaba-cho, Sendai, Sunto-gun, Shibuya-ku, Akita
2021-10-04
Active, closed
Pfizer
Phase 3
599
Nagoya, Hirosaki, Chiba, Kashiwa, Matsuyama, Fukuoka, Kure, Sapporo
2021-05-12
Active, closed
Pfizer
Phase 3
841
Chiba, Kashiwa, Sapporo, Kanazawa, Kawasaki, Yokohama, Nagoya, Osaka
2020-12-21
Recruiting
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
NCT04606446Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer
Pfizer
Phase 2
320
Nagoya, Kashiwa, Yokohama, Chuo-ku
2020-11-16
Active, closed
Pfizer
Phase 3
114
Nagoya, Nishinomiya, Tokyo
2020-11-05
Active, closed
Pfizer
Phase 3
896
Nagoya, Toyohashi, Kashiwa-shi, Nagareyama-shi, Sakura, Fukuoka, Kasuga, Kasuga-shi
2019-09-05
Active, closed
Pfizer
Phase 3
1,054
Nagoya, Hirosaki, Kashiwa, Matsuyama, Kure, Sapporo, Kanazawa, Yokohama
2017-12-18
Active, closed
Pfizer
Phase 3
296
Nagoya, Matsuyama, Kurume, Sapporo, Kanazawa, Yokohama, Sendai, Osaka
2017-04-27
Rows per page Showing 1–31 of 31
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 October 2026. https://priyalifescience.com/clinical-trials-japan/city/nagoya

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,493 studies in total at the last sync on 22 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 31 of those studies with a site in Nagoya that also match the filters currently applied.

How many clinical trials are recruiting in Nagoya?

13 of the 31 studies on this page are recruiting new participants as of the 22 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 18 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Nagoya), 31 studies
PhaseStudiesRecruitingShare
Phase 320764.5%
Phase 2329.7%
Phase 2/3339.7%
Phase 1/2216.5%
Phase 4206.5%
Phase 1103.2%

Most active sponsors

Lead sponsors with the most studies (Nagoya)
Lead sponsorStudiesRecruiting
Pfizer3113
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.